7 min

Biden's EV Tariffs, AI Drug Success & Renewable Energy Paradox (+5 more stories‪)‬ The Daily Business & Finance Show

    • Business News

The Daily Business and Finance Show - Saturday, 11 May 2024 We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days!



Please click here for more info: Subscribe to Seeking Alpha Premium News
Today's headlines:
Biden set to announce 100% tariffs on Chinese EVs
AI-discovered drugs have an 80%–90% success rate: study
Global renewable energy grew by 30%, but demand is still too high for supply - Ember
Marijuana THC potency at all-time high - DEA
Bitcoin stands to gain from U.S. fiscal dominance, Trump victory: StanChart
Nasdaq, S&P, Dow end solidly higher for the week as investors eye CPI data
Cannabis rescheduling unlikely to happen by end of year -- Seeking Alpha survey
Bristol Myers' Opdivo fails in Phase 3 lung cancer study

Explanations from OpenAI ChatGPT API with proprietary prompts.
This podcast provides information only and should not be construed as financial or business advice.
This podcast is produced by Klassic Studios
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Daily Business and Finance Show - Saturday, 11 May 2024 We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days!



Please click here for more info: Subscribe to Seeking Alpha Premium News
Today's headlines:
Biden set to announce 100% tariffs on Chinese EVs
AI-discovered drugs have an 80%–90% success rate: study
Global renewable energy grew by 30%, but demand is still too high for supply - Ember
Marijuana THC potency at all-time high - DEA
Bitcoin stands to gain from U.S. fiscal dominance, Trump victory: StanChart
Nasdaq, S&P, Dow end solidly higher for the week as investors eye CPI data
Cannabis rescheduling unlikely to happen by end of year -- Seeking Alpha survey
Bristol Myers' Opdivo fails in Phase 3 lung cancer study

Explanations from OpenAI ChatGPT API with proprietary prompts.
This podcast provides information only and should not be construed as financial or business advice.
This podcast is produced by Klassic Studios
Learn more about your ad choices. Visit megaphone.fm/adchoices

7 min